4.8 Article

Robust Microflow LC-MS/MS for Proteome Analysis: 38 000 Runs and Counting

期刊

ANALYTICAL CHEMISTRY
卷 93, 期 8, 页码 3686-3690

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.1c00257

关键词

-

资金

  1. Alexander von Humboldt Foundation
  2. Carl Friedrich von Siemens Foundation
  3. National Natural Science Foundation of China [81600046]
  4. German Science foundation (DFG) [SFB1309, 325871075, SFB1321, 329628492]
  5. German Ministry for Science and Research (BMBF) [031L0008A]
  6. ERC [833710]
  7. European Research Council (ERC) [833710] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Microflow liquid chromatography tandem mass spectrometry (mu LC-MS/MS) has been shown to be a robust and high-throughput method for analyzing proteomes, capable of measuring thousands of proteins from various samples. The system demonstrated the potential for in-depth and high-throughput clinical applications through analyzing a large number of samples over a period of two years.
Microflow liquid chromatography tandem mass spectrometry (mu LC-MS/MS) is becoming a viable alternative to nanoflow LC-MS/MS for the analysis of proteomes. We have recently demonstrated the potential of such a system operating with a 1 mm i.d. X 150 mm column and at a flow rate of 50 mu L/ min for high-throughput applications. On the basis of the analysis of similar to 38 000 samples measured on two instruments over the past two years, we now show that the approach is extremely robust. Up to 1500 analyses were performed within one month, and >14 000 samples could be analyzed on a single column without loss of chromatographic performance. Samples included proteomes of cell lines, tissues, and human body fluids, which were analyzed with or without prior peptide fractionation or stable isotope labeling. We show that the mu LC-MS/MS system is capable of measuring 2600 proteins from undepleted human plasma and similar to 5000 proteins from crude human urine in 1 day, demonstrating its potential for in-depth as well as high-throughput clinical application.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据